Thursday April 20, 2017

New Board Members Named at AGM

New Board Members Named at Cannabis Canada Association Annual General Meeting

April 20, 2017 – Ottawa, Ontario – Cannabis Canada is pleased to announce that several new members were named to the Association’s Board of Directors at its annual general meeting on April 10.

Neil Closner, CEO of MedReleaf was confirmed for another term as Chairman of the Board of the Association. Several new members joined the Board. They are Allan Rewak, of Newstrike; John Stewart of Emblem Cannabis; and Sébastien St. Louis of The Hydropothecary.

“Our Board will greatly benefit from the continued sage counsel of Mr. Closner and the enthusiasm and fresh perspective of our newly appointed members – including a representative of one of the newest companies to join the Association,” said Colette Rivet, Cannabis Canada’s Executive Director. “With our new Board members in place, and new oversight measures in development, we are ready to ensure that high-quality, tested cannabis products are available, as the Government of Canada prepares to table legislation for the legalization and regulation of cannabis in Canada.”

About Cannabis Canada Association

Cannabis Canada is the leading organization of Canada’s Licensed Producers of Medical Cannabis under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).

The Association’s mission is to act as the national voice for our members in their promotion of industry standards; support the development, growth and integrity of the regulated cannabis industry; and serve as an important resource on issues related to the safe and responsible use of cannabis for medical and non-medical purposes.

Members of Cannabis Canada share a philosophy of both patient-centric care and improved public health, and are committed to product safety and quality, secure and reliable access and the promotion of the safe and healthful use of cannabis. Website: www.cann-can.ca

Cannabis Canada Association

Cannabis Canada Association, collectively, represents the majority of Licensed Producers of cannabis for medical purposes as licensed and regulated by the Office of Medical Cannabis and the Controlled Substance and Tobacco Branch, under the Health Canada’s Marijuana for Medical Purposes Regulations (MMPR), in force as of April 1, 2014, recently modified on August 24, 2016 and renamed Access to Cannabis for Medical Purposes Regulations (ACMPR).